CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Health

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 17, 2025

Income

$30,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Metachromatic Leukodystrophy included on Recommended Uniform Screening Panel (RUSP) Metachromatic Leukodystrophy treatment

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.